Red blood cell arginase suppresses Jurkat (T cell) proliferation by depleting arginine

被引:18
作者
Bernard, Andrew [1 ]
Kasten, Michael [1 ]
Meier, Cindy [1 ]
Manning, Erin [1 ]
Freeman, Stephanie [1 ]
Adams, Will [1 ]
Chang, Phillip [1 ]
Boulanger, Bernard [1 ]
Kearney, Paul [1 ]
机构
[1] Univ Kentucky, Coll Med, Dept Surg, Div Gen Surg,Trauma Crit Care Res Program, Lexington, KY 40536 USA
关键词
D O I
10.1016/j.surg.2007.07.037
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Transfusion of packed red blood cells (PRBC) suppresses immunity, but the mechanisms are incompletely understood. PRBCs contain arginase, an enzyme which converts arginine to ornithine and depletes arginine in vitro. Arginine depletion suppresses proliferation of Jurkat T cells in other models. We hypothesize that PRBC arginase-mediated arginine depletion will suppress proliferation of T cells. Methods. A transfusion model was designed adding PRBC to culture RPMI media with or without an irreversible arginase blocker (nor-NOHA), incubating for 6-48 hours and then removing the PRBCs. Amino acid concentrations in the media were measured using liquid chromatography mass spectrometry. T cells were then added to the pre-conditioned media, cultured for 24 hours, and proliferation was measured. Results. PRBC depleted arginine significantly and increased ornithine in media compared to baseline PRBC treated wells and significantly decreased T cell proliferation. These effects were enhanced with volume of PRBC exposure. Nor-NOHA inhibition of arginase restored T cell proliferation in PRBC treated cultures. Conclusions. Jurkat T cell proliferation was impaired by PRBC in clinically relevant volumes. The mechanism influencing T cell impairment appears to result from arginine depletion by arginase. Arginine depletion by PRBC arginase may be a novel mechanism for immunosuppression after transfusion.
引用
收藏
页码:286 / 291
页数:6
相关论文
共 24 条
[21]   Transfusion of the injured patient: Proceed with caution [J].
Silliman, CC ;
Moore, EE ;
Johnson, JL ;
Gonzalez, RJ ;
Biffl, WL .
SHOCK, 2004, 21 (04) :291-299
[22]   Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications - Results of a double-blinded, randomized study [J].
Titlestad, IL ;
Ebbesen, LS ;
Ainsworth, AP ;
Lillevang, ST ;
Qvist, N ;
Georgsen, J .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2001, 16 (03) :147-153
[23]   Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? [J].
Vamvakas, EC ;
Blajchman, MA .
BLOOD, 2001, 97 (05) :1180-1195
[24]   Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence [J].
van de Watering, LMG ;
Brand, A ;
Houbiers, JGA ;
Kranenbarg, WMK ;
Hermans, J ;
van de Velde, CJH .
BRITISH JOURNAL OF SURGERY, 2001, 88 (02) :267-272